Wellinks’ First Wireless Nebulizer for COPD Cleared for Patient Study

Wellinks’ First Wireless Nebulizer for COPD Cleared for Patient Study

283746

Wellinks’ First Wireless Nebulizer for COPD Cleared for Patient Study

A pilot study on the first wireless nebulizer for use by people with chronic obstructive pulmonary disease (COPD) has been cleared by a review board of the U.S. Food and Drug Administration (FDA), Wellinks, the nebulizer’s developer, announced. “Getting into the field with our first digital health offering and welcoming patients on the platform is an exciting milestone for us,” Geoff Matous, Wellinks’ president, said in a press release. It is estimated that about 25…

You must be logged in to read/download the full post.